Ameritas Investment Partners’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.4K | Hold |
1,202
| – | – | ﹤0.01% | 2653 |
|
|
2025
Q4 | $11.6K | Hold |
1,202
| – | – | ﹤0.01% | 2865 |
|
|
2025
Q3 | $11.3K | Hold |
1,202
| – | – | ﹤0.01% | 2911 |
|
|
2025
Q2 | $12.7K | Hold |
1,202
| – | – | ﹤0.01% | 2882 |
|
|
2025
Q1 | $18.1K | Hold |
1,202
| – | – | ﹤0.01% | 2598 |
|
|
2024
Q4 | $19.8K | Hold |
1,202
| – | – | ﹤0.01% | 2644 |
|
|
2024
Q3 | $29.7K | Hold |
1,202
| – | – | ﹤0.01% | 2463 |
|
|
2024
Q2 | $30.4K | Hold |
1,202
| – | – | ﹤0.01% | 2417 |
|
|
2024
Q1 | $30.5K | Hold |
1,202
| – | – | ﹤0.01% | 2395 |
|
|
2023
Q4 | $27.2K | Hold |
1,202
| – | – | ﹤0.01% | 2445 |
|
|
2023
Q3 | $22.4K | Hold |
1,202
| – | – | ﹤0.01% | 2491 |
|
|
2023
Q2 | $31.2K | Hold |
1,202
| – | – | ﹤0.01% | 2311 |
|
|
2023
Q1 | $34.5K | Hold |
1,202
| – | – | ﹤0.01% | 2199 |
|
|
2022
Q4 | $36.3K | Hold |
1,202
| – | – | ﹤0.01% | 2265 |
|
|
2022
Q3 | $28K | Hold |
1,202
| – | – | ﹤0.01% | 2335 |
|
|
2022
Q2 | $26K | Hold |
1,202
| – | – | ﹤0.01% | 2405 |
|
|
2022
Q1 | $30K | Hold |
1,202
| – | – | ﹤0.01% | 2358 |
|
|
2021
Q4 | $43K | Hold |
1,202
| – | – | ﹤0.01% | 2212 |
|
|
2021
Q3 | $51K | Hold |
1,202
| – | – | ﹤0.01% | 2134 |
|
|
2021
Q2 | $52K | Hold |
1,202
| – | – | ﹤0.01% | 2141 |
|
|
2021
Q1 | $49K | Hold |
1,202
| – | – | ﹤0.01% | 2091 |
|
|
2020
Q4 | $54K | Hold |
1,202
| – | – | ﹤0.01% | 1944 |
|
|
2020
Q3 | $43K | Hold |
1,202
| – | – | ﹤0.01% | 1924 |
|
|
2020
Q2 | $45K | Hold |
1,202
| – | – | ﹤0.01% | 1889 |
|
|
2020
Q1 | $35K | Hold |
1,202
| – | – | ﹤0.01% | 1855 |
|
|
2019
Q4 | $62K | Hold |
1,202
| – | – | ﹤0.01% | 1786 |
|
|
2019
Q3 | $66K | Hold |
1,202
| – | – | ﹤0.01% | 1710 |
|
|
2019
Q2 | $49K | Hold |
1,202
| – | – | ﹤0.01% | 1919 |
|
|
2019
Q1 | $36K | Hold |
1,202
| – | – | ﹤0.01% | 2062 |
|
|
2018
Q4 | $40K | Hold |
1,202
| – | – | ﹤0.01% | 1934 |
|
|
2018
Q3 | $51K | Hold |
1,202
| – | – | ﹤0.01% | 1983 |
|
|
2018
Q2 | $38K | Buy |
1,202
+60
| +5% | +$2.47K | ﹤0.01% | 2158 |
|
|
2018
Q1 | $57K | Hold |
1,142
| – | – | ﹤0.01% | 1847 |
|
|
2017
Q4 | $62K | Hold |
1,142
| – | – | ﹤0.01% | 1795 |
|
|
2017
Q3 | $61K | Hold |
1,142
| – | – | ﹤0.01% | 1754 |
|
|
2017
Q2 | $56K | Hold |
1,142
| – | – | ﹤0.01% | 1836 |
|
|
2017
Q1 | $50K | Buy |
+1,142
| New | +$54.5K | ﹤0.01% | 1831 |
|
Other funds holding ANIK
CP
VCM
BFM
CM
Ameritas Investment Partners's ANIK Position: Q1 2026 in Review
Ameritas Investment Partners held its Anika Therapeutics (ANIK) position steady in Q1 2026 at 1,202 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2653.
Ameritas Investment Partners first reported a position in ANIK in Q1 2017 and has held it in 37 quarters since. The position peaked at $66K in Q3 2019. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.
- Ameritas Investment Partners held 1,202 shares of Anika Therapeutics worth $17.4K as of Q1 2026.
- Ameritas Investment Partners left its Anika Therapeutics share count unchanged in Q1 2026.
- Anika Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2653 holding.
- Ameritas Investment Partners first reported a position in Anika Therapeutics in Q1 2017 and has held it in 37 quarters since.
- Ameritas Investment Partners's Anika Therapeutics position peaked at $66K in Q3 2019.
- 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.